Brevetoxin Metabolites: Emerging Toxins in French Shellfish Determined by LC-MS/MS and ELISA
Marine Drugs · 03.02.2026 · 24 (2) · 67
DOI: 10.3390/md24020067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 03.02.2026. Verfasst von Zouher Amzil und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ifremer (French Research Institute for Exploitation of the Sea)/PHYTOX/METALG, F-44311 Nantes, France. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Directorate for Food of the Ministry of Agriculture and Food, General Directorate for Food of the Ministry of Agriculture and Food.
Abstract (Originalsprache)
In France, as part of the monitoring program for the emergence of marine toxins in shellfish (EMERGTOX), brevetoxins (BTX-2, BTX-3) were first detected in shellfish from Corsica (Mediterranean Sea) in 2018. The complex metabolic transformation of brevetoxins in shellfish, coupled with the limited availability of analytical standards for most metabolites, complicates the accurate evaluation of contamination levels. To address this challenge, two complementary analytical approaches were implemented to quantify brevetoxin metabolites in shellfish samples collected from 2018 to 2023: (i) a targeted LC-MS/MS method specially developed for brevetoxins; and (ii) an ELISA capable of detecting metabolites for which no reference standards are available. Of the 11 brevetoxin metabolites targeted, 4 were quantified by LC-MS/MS: BTX-2, BTX-3, BTX-B5, and S-deoxy-BTX-B2 (including its isomers). The ELISA consistently detected brevetoxins in all Corsican samples previously confirmed positive by LC-MS/MS, with concentrations systematically exceeding those measured by LC-MS/MS. This overestimation may result from antibody cross-reactivity and from the presence of unidentified brevetoxin metabolites not detected by LC-MS/MS. Regardless of the analytical method used, the highest concentration detected exceeded the current French guideline value for brevetoxins in shellfish. To ensure consumer protection, a two-step monitoring strategy is proposed: initial screening via ELISA to estimate brevetoxin contamination, followed by confirmatory LC-MS/MS analysis to identify and quantify the specific metabolites.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ifremer (French Research Institute for Exploitation of the Sea)/PHYTOX/METALG, F-44311 Nantes, France.
- Ifremer (French Research Institute for Exploitation of the Sea)/COAST/LER-BO, F-29900 Concarneau, France.
ORCID-Profile: Zouher Amzil, Amélie Derrien, Aouregan Terre Terrillon
Förderung
- Directorate for Food of the Ministry of Agriculture and Food
- General Directorate for Food of the Ministry of Agriculture and Food
Zitieren
APA
Amzil, Z., Derrien, A., Lhaute, K., Terrillon, A. T., & Tanniou, S. (2026). Brevetoxin Metabolites: Emerging Toxins in French Shellfish Determined by LC-MS/MS and ELISA. Marine Drugs, 24(2), 67. https://doi.org/10.3390/md24020067
Vancouver
Amzil Z, Derrien A, Lhaute K, Terrillon AT, Tanniou S. Brevetoxin Metabolites: Emerging Toxins in French Shellfish Determined by LC-MS/MS and ELISA. Marine Drugs. 2026;24(2):67. doi:10.3390/md24020067
BibTeX
@article{Amzil2026,
author = {Amzil, Zouher and Derrien, Amélie and Lhaute, Korian and Terrillon, Aouregan Terre and Tanniou, Simon},
title = {Brevetoxin Metabolites: Emerging Toxins in French Shellfish Determined by LC-MS/MS and ELISA},
journal = {Marine Drugs},
year = {2026},
volume = {24},
number = {2},
pages = {67},
doi = {10.3390/md24020067}
}
EUVIMED